ASX Announcements

31st Dec Appendix 3B
22nd Nov Appendix 3B
22nd Nov Appendix 3Y
22nd Nov Results of Annual General Meeting
22nd Nov Presentation
14th Nov Meluka Honey Secures Distribution for NSW & ACT
12th Nov Change of Director's Interest Notice
9th Nov Southern Cross University Media Release
8th Nov Meluka Honey Combines Anti-Microbial & Anti-Oxidant Activity
25th Oct Quarterly Review
19th Oct Notice of Annual General Meeting and Proxy Form
19th Oct Appendix 4G and Corporate Governance Statement
19th Oct Annual Report to Shareholders
18th Oct Notice of change of interests of substantial holder
15th Oct Appendix 4E and Full Year Statutory Accounts
12th Sep Omni Innovation - Update by Eagle Health
12th Sep Presentation
30th Aug Completion of Jenbrook Transaction
30th Aug Appendix 3B
30th Aug Prospectus
24th Aug Results of General Meeting
25th Jul Quarterly Review
24th Jul Completion of THC Agreements
23rd Jul Notice of General Meeting/Proxy Form
16th Jul Update by Eagle Health on Chinese Market
3rd Jul Update on THC Agreements
21st Jun EVE to Acquire Leading Australian Organic Tea Tree Oil Producer
19th Jun Trading Halt
31st May Eagle Plans to Significantly Expand China Distribution
29th May Corporate Update
3rd May Meluka Health and THC Execute Term Sheet
30th Apr Quarterly Review
26th Apr First Quarter China Sales Progress
5th Apr Net Tangible Asset Backing
4th Apr Change of Director's Interest Notice x 4
4th Apr Appendix 3B
28th Mar Allotment of Rights Issue Shortfall
14th Mar Net Tangible Asset Backing
14th Mar Investor Presentation
6th Mar Completion of Rights Issue
26th Feb Half Yearly Report and Accounts
23rd Feb Meluka Honey Consumer Products Launch at US Natural Products Expo
19th Feb Rights Issue Offer Document
14th Feb Omni Innovation Update by Eagle on Chinese Rollout
13th Feb Eagle Commences Marketing and Sales in China
13th Feb Net Tangible Asset Backing
12th Feb Letter to Shareholders
9th Feb Letter to Optionholders
9th Feb Appendix 3B and Section 708AA(2)(f) Notice
9th Feb Pro-Rata Non-Renounceable Rights Offer
8th Feb Appendix 3B
7th Feb Appendix 3B
6th Feb Capital Raising Update
6th Feb Prospectus
31st Jan Appendix 3B
31st Jan Quarterly Review
31st Jan Change to Board Roles
31st Jan Oversubscribed Placement and Rights Issue to Raise up to $6.3m
25th Jan Trading Halt
18th Jan Appendix 3B

Adobe Acrobat Reader 5.0 or later needed to view PDF files. Get Acrobat Reader